Literature DB >> 21800140

Increase in number of sporadic inclusion body myositis (sIBM) in Japan.

Naoki Suzuki, Masashi Aoki, Madoka Mori-Yoshimura, Yukiko K Hayashi, Ikuya Nonaka, Ichizo Nishino.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21800140     DOI： 10.1007/s00415-011-6185-8

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  9 in total

Review 1.  Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition.

Authors:  Valerie Askanas; W King Engel
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

Review 2.  Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches.

Authors:  Merrilee Needham; Frank L Mastaglia
Journal:  Lancet Neurol       Date:  2007-07       Impact factor: 44.182

Review 3.  Inclusion body myositis: a degenerative muscle disease associated with intra-muscle fiber multi-protein aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased lysosomal degradation.

Authors:  Valerie Askanas; W King Engel; Anna Nogalska
Journal:  Brain Pathol       Date:  2009-07       Impact factor: 6.508

4.  Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis.

Authors:  Merrilee Needham; Alastair Corbett; Timothy Day; Frank Christiansen; Vicki Fabian; Frank L Mastaglia
Journal:  J Clin Neurosci       Date:  2008-09-23       Impact factor: 1.961

Review 5.  Polymyositis and dermatomyositis.

Authors:  Marinos C Dalakas; Reinhard Hohlfeld
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

6.  Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis.

Authors:  Mohammad Salajegheh; Jack L Pinkus; J Paul Taylor; Anthony A Amato; Remedios Nazareno; Robert H Baloh; Steven A Greenberg
Journal:  Muscle Nerve       Date:  2009-07       Impact factor: 3.217

Review 7.  Inclusion body myositis: old and new concepts.

Authors:  A A Amato; R J Barohn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-11       Impact factor: 10.154

8.  Rabbits fed cholesterol-enriched diets exhibit pathological features of inclusion body myositis.

Authors:  Xuesong Chen; Othman Ghribi; Jonathan D Geiger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-01-23       Impact factor: 3.619

Review 9.  Genetics of inclusion-body myositis.

Authors:  M Needham; F L Mastaglia; M J Garlepp
Journal:  Muscle Nerve       Date:  2007-05       Impact factor: 3.217
  9 in total
  14 in total

1.  Clinical, pathological, and genetic mutation analysis of sporadic inclusion body myositis in Japanese people.

Authors:  Huaying Cai; Ichiro Yabe; Kazunori Sato; Takahiro Kano; Masakazu Nakamura; Hideki Hozen; Hidenao Sasaki
Journal:  J Neurol       Date:  2012-02-17       Impact factor: 4.849

2.  A dysphagia study in patients with sporadic inclusion body myositis (s-IBM).

Authors:  Ken-Ya Murata; Ken Kouda; Fumihiro Tajima; Tomoyoshi Kondo
Journal:  Neurol Sci       Date:  2011-10-13       Impact factor: 3.307

3.  Cricopharyngeal bar on videofluoroscopy: high specificity for inclusion body myositis.

Authors:  Kenichiro Taira; Toshiyuki Yamamoto; Madoka Mori-Yoshimura; Kazuaki Sajima; Hotake Takizawa; Jun Shinmi; Yasushi Oya; Ichizo Nishino; Yuji Takahashi
Journal:  J Neurol       Date:  2020-09-26       Impact factor: 4.849

4.  Epidemiology and Natural History of Inclusion Body Myositis: A 40-Year Population-Based Study.

Authors:  Shahar Shelly; Michelle M Mielke; Jay Mandrekar; Margherita Milone; Floranne C Ernste; Elie Naddaf; Teerin Liewluck
Journal:  Neurology       Date:  2021-04-20       Impact factor: 11.800

5.  Multicenter questionnaire survey for sporadic inclusion body myositis in Japan.

Authors:  Naoki Suzuki; Madoka Mori-Yoshimura; Satoshi Yamashita; Satoshi Nakano; Ken-Ya Murata; Yukie Inamori; Naoko Matsui; En Kimura; Hirofumi Kusaka; Tomoyoshi Kondo; Itsuro Higuchi; Ryuji Kaji; Maki Tateyama; Rumiko Izumi; Hiroya Ono; Masaaki Kato; Hitoshi Warita; Toshiaki Takahashi; Ichizo Nishino; Masashi Aoki
Journal:  Orphanet J Rare Dis       Date:  2016-11-08       Impact factor: 4.123

6.  Development and evaluation of a standardized ELISA for the determination of autoantibodies against cN-1A (Mup44, NT5C1A) in sporadic inclusion body myositis.

Authors:  Sabine L Kramp; Dmitry Karayev; Guo Shen; Allan L Metzger; Robert I Morris; Eugene Karayev; Yvonne Lam; Richard M Kazdan; Ger J M Pruijn; Sandra Saschenbrecker; Cornelia Dähnrich; Wolfgang Schlumberger
Journal:  Auto Immun Highlights       Date:  2016-11-17

7.  Mortality and Causes of Death in Patients with Sporadic Inclusion Body Myositis: Survey Study Based on the Clinical Experience of Specialists in Australia, Europe and the USA.

Authors:  Mark A Price; Victoria Barghout; Olivier Benveniste; Lisa Christopher-Stine; Alastair Corbett; Marianne de Visser; David Hilton-Jones; John T Kissel; Thomas E Lloyd; Ingrid E Lundberg; Francis Mastaglia; Tahseen Mozaffar; Merrilee Needham; Jens Schmidt; Kumaraswamy Sivakumar; Carla DeMuro; Brian S Tseng
Journal:  J Neuromuscul Dis       Date:  2016-03-03

Review 8.  Immune and myodegenerative pathomechanisms in inclusion body myositis.

Authors:  Christian W Keller; Jens Schmidt; Jan D Lünemann
Journal:  Ann Clin Transl Neurol       Date:  2017-05-16       Impact factor: 4.511

Review 9.  Ongoing developments in sporadic inclusion body myositis.

Authors:  Pedro M Machado; Mhoriam Ahmed; Stefen Brady; Qiang Gang; Estelle Healy; Jasper M Morrow; Amanda C Wallace; Liz Dewar; Gita Ramdharry; Matthew Parton; Janice L Holton; Henry Houlden; Linda Greensmith; Michael G Hanna
Journal:  Curr Rheumatol Rep       Date:  2014-12       Impact factor: 4.592

Review 10.  Sporadic inclusion body myositis: the genetic contributions to the pathogenesis.

Authors:  Qiang Gang; Conceição Bettencourt; Pedro Machado; Michael G Hanna; Henry Houlden
Journal:  Orphanet J Rare Dis       Date:  2014-06-19       Impact factor: 4.123
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.